MSI-78 topical anti-infective: Began Phase III trial

Magainin Pharmaceuticals Inc. (MAGN), Plymouth Meeting, Penn. Product: MSI-78 topical anti-infective Indication: Infected diabetic foot ulcers Status: Began Phase III trial in 400-500 patients compari...